In the ever-evolving world of biotechnology, little remains constant. For Annick Deschoolmeester, head of human resources at Swiss biopharma company Pharvaris, this perpetual drive toward innovation in human health is what keeps her drawn to the sector. “At the end of the day, we think back about why we come to work and why we do […]

Bothell-based biotech Athira Pharma (Nasdaq: ATHA) has appointed Grant Pickering, CEO and co-founder of the California-based vaccine company Vaxcyte, to its board of directors. “Grant is an accomplished life sciences leader with considerable experience across all stages of development and commercialization of new medicines,” Mark Litton, president and CEO at Athira, said in a news release. “His […]

Athira Pharma has dosed the first patient in its Phase 2 clinical trial evaluating ATH-1017 as a treatment for Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) — forms of more severe cognitive impairment in Parkinson’s disease. The trial (NCT04831281), known as SHAPE, is still recruiting patients, ages 40-85, at five different locations across the United […]